GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (NAS:SCTL) » Definitions » Piotroski F-Score
中文

Societal CDMO (Societal CDMO) Piotroski F-Score : 4 (As of Apr. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Societal CDMO Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Societal CDMO has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Societal CDMO's Piotroski F-Score or its related term are showing as below:

SCTL' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 4

During the past 13 years, the highest Piotroski F-Score of Societal CDMO was 6. The lowest was 2. And the median was 4.


Societal CDMO Piotroski F-Score Historical Data

The historical data trend for Societal CDMO's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO Piotroski F-Score Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 6.00 2.00 4.00

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 3.00 3.00 3.00 4.00

Competitive Comparison of Societal CDMO's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societal CDMO's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Societal CDMO's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -4.684 + -3.212 + -4.592 + -0.786 = $-13.27 Mil.
Cash Flow from Operations was -2.853 + 1.225 + -0.904 + 1.527 = $-1.01 Mil.
Revenue was 21.527 + 21.799 + 23.59 + 27.719 = $94.64 Mil.
Gross Profit was 2.248 + 4.472 + 3.72 + 7.698 = $18.14 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(157.443 + 149.938 + 148.736 + 151.53 + 153.474) / 5 = $152.2242 Mil.
Total Assets at the begining of this year (Dec22) was $157.44 Mil.
Long-Term Debt & Capital Lease Obligation was $4.49 Mil.
Total Current Assets was $53.46 Mil.
Total Current Liabilities was $49.99 Mil.
Net Income was -4.264 + -3.119 + -3.329 + -9.169 = $-19.88 Mil.

Revenue was 21.194 + 23.152 + 21.589 + 24.279 = $90.21 Mil.
Gross Profit was 5.08 + 5.682 + 5.534 + 6.842 = $23.14 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(160.317 + 151.799 + 153.359 + 151.279 + 157.443) / 5 = $154.8394 Mil.
Total Assets at the begining of last year (Dec21) was $160.32 Mil.
Long-Term Debt & Capital Lease Obligation was $35.55 Mil.
Total Current Assets was $55.59 Mil.
Total Current Liabilities was $22.81 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Societal CDMO's current Net Income (TTM) was -13.27. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Societal CDMO's current Cash Flow from Operations (TTM) was -1.01. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-13.274/157.443
=-0.08430988

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-19.881/160.317
=-0.12401055

Societal CDMO's return on assets of this year was -0.08430988. Societal CDMO's return on assets of last year was -0.12401055. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Societal CDMO's current Net Income (TTM) was -13.27. Societal CDMO's current Cash Flow from Operations (TTM) was -1.01. ==> -1.01 > -13.27 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=4.492/152.2242
=0.02950911

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=35.551/154.8394
=0.22959918

Societal CDMO's gearing of this year was 0.02950911. Societal CDMO's gearing of last year was 0.22959918. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=53.461/49.987
=1.06949807

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=55.586/22.808
=2.43712732

Societal CDMO's current ratio of this year was 1.06949807. Societal CDMO's current ratio of last year was 2.43712732. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Societal CDMO's number of shares in issue this year was 104.851. Societal CDMO's number of shares in issue last year was 61.892. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=18.138/94.635
=0.1916627

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=23.138/90.214
=0.25647904

Societal CDMO's gross margin of this year was 0.1916627. Societal CDMO's gross margin of last year was 0.25647904. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=94.635/157.443
=0.60107467

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=90.214/160.317
=0.56272261

Societal CDMO's asset turnover of this year was 0.60107467. Societal CDMO's asset turnover of last year was 0.56272261. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Societal CDMO has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Societal CDMO  (NAS:SCTL) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Societal CDMO Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Societal CDMO's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (Societal CDMO) Business Description

Traded in Other Exchanges
N/A
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.
Executives
Bryan M. Reasons director C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544
Elena Cant director C/O SOCIETAL CDMO, INC., 1 E. UWCHLAN AVENUE, SUITE 112, EXTON PA 19341
Enloe J David Jr director, officer: Chief Executive Officer
James Charles Miller director 490 LAPP ROAD, MALVERN PA 19355
Wayne Weisman director 490 LAPP ROAD, MALVERN PA 19355
William Ashton director C/O HARRISON CONSULTING GROUP, PO BOX 283, NEWTOWN SQUARE PA 19073
Winston J Churchill director C/O SCP PARTNERS, SUITE 300, 1200 LIBERTY RIDGE DRIVE, WAYNE PA 19087
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Mathew Paul Arens director, 10 percent owner C/O FIRST LIGHT ASSET MANAGEMENT, LLC, 3300 EDINBOROUGH WAY, SUITE 201, EDINA MN 55435
First Light Asset Management, Llc director, 10 percent owner 3300 EDINBOROUGH WAY, SUITE 201, EDINA MN 55435
Laura L. Parks director C/O RECRO PHARMA, INC., 490 LAPP ROAD, MALVERN PA 29355
Michael Berelowitz director 415 EAST 37TH STREET, APT 36C, NEW YORK NY 10016
Ryan David Lake officer: Chief Financial Officer KENSEY NASH CORPORATION, 735 PENNSYLVANIA DRIVE, EXTON PA 19341
Scp Vitalife Partners (israel) Ii, L.p. 10 percent owner SUITE 190, 7 GREAT VALLEY PARKWAY, MALVERN PA 19355
Scp Vitalife Partners Ii Lp 10 percent owner SUITE 190, 7 GREAT VALLEY PARKWAY, MALVERN PA 19355